🦊/Investors

Tenmile

Venture capitaloperating company · company profile

Seed–Growth · 11 people tracked

Find your way into Tenmile

1,702 people in our graph share verified history with the Tenmile team — schools, employers, funds. One of them is your warm intro.

Vinnie Lauriaunlockedknows Michael Lamprecht · together at Boston University (overlapped)
knows the team · via UCL
×2knows the team · via University of Oxford
knows the team · via Babson College
knows the team · via Massachusetts Institute of Technology
knows the team · via Monash University
Fox Verdict
Sign up to see your fit

Investment thesis

Tenmile invests in teams addressing major unmet needs in human health, backing bold ideas with capital, expertise, and conviction to produce better health outcomes alongside strong commercial returns. The firm seeks to make Australia a global health leader by helping translate scientific breakthroughs into scalable, global solutions, bridging the gap between breakthrough research and global impact. Its team combines sector knowledge across medicine, academia, tech transfer, pharma, biotech, and investment banking to support founders. Tenmile invests from seed and beyond across six current focus areas, positioning itself as a founder-first, impact-driven partner offering more than capital.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Growth
Instruments
Equity
Last 12 months
1 investment
Tracked investments
39
Acquisitions
1

Team · 11 people

from the firm's website

Founder mafia

3 people who came through Tenmile went on to found or lead other companies.

What they invest in

from 29 of 39 portfolio companies

Biotech ×20Healthtech ×15Medical Devices ×15AI & Machine Learning ×11Digital Health ×11Deep Tech ×8Mental Health ×3SaaS ×3

HQs:Australia×9United States×6

Who they back

founder profiles across 12 portfolio companies
33%
solo founders
4 of 12 mapped founding teams
29%
repeat founders
of 14 founders with career history

Founding team size:solo founder×42 founders×73 founders×1

Where their founders studiedfrom 15 founders with education data

Princeton University ×3Monash University ×2Penn State University ×2The University of Texas at Austin ×2University of Sydney ×2UNSW ×2

What their founders studiedfrom 14 founders with field-of-study data

Life Sciences ×7Computer Science ×2Economics ×2

Where their founders worked beforefrom 14 founders with career history

Revagenix, Inc. ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×2

Investments · 39 tracked

founders shown can be your intro path

By year:2026 · 12024 · 42023 · 12022 · 28 dated

Aravaxaravax.com.auinJan 2024 · $66M✓ verified

Aravax is a clinical-stage biotechnology company developing next-generation immunotherapies to treat food allergies.

BiotechHealthtechMedical DevicesMelbourne, AU

Sara Prickett(Co-founder)in

Co-investorsNovartis Venture FundBreakthrough VictoriaUniSeed Pty Ltd.

Revagenixrevagenix.cominJan 2024✓ verified

Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.

BiotechDeep TechHealthtechMedical Devices

Ryan Cirz(Co-founder & CEO)inAndrew McCandlish(Co-founder & COO)inPeter Smith(Chief Scientific Officer)inDaniel Cloutier(VP, Development)in

Co-investorsNovo Holdings

AdvanCelladvancell.com.auinJun 2026

AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.

BiotechHealthtechMedical DevicesCambridge, US

Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in

BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)

Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSV Health InvestorsAbingworthAlly Bridge Group+2 more

Amaroq Therapeuticsamaroqtx.comin

Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.

Biotech

Co-investorsBooster Innovation FundCure Kids VenturesBrandon Capital Partners

Antares Therapeuticsantaresrx.comin𝕏

Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases.

AI & Machine LearningBiotechMedical DevicesCambridge, US

Adam Friedman(Chief Executive Officer)inAndrew Fedder(Executive Officer, Director)inBrian Piper(Executive Officer, Director)in

Co-investorsAtlas VentureLightspeed Venture PartnersVida VenturesOmega FundsAbingworthAlleyCorp+1 more

Ausbiotechausbiotech.orgin

AusBiotech is the national industry association representing Australia's life sciences ecosystem, advocating for policy, facilitating connections, and supporting growth for biotechnology, medical technologies, and digital health companies.

BiotechDigital HealthMedical DevicesBrisbane, AU

Rebekah Cassidyin

Carina Biotechcarinabiotech.comin𝕏Aug 2022

Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system.

BiotechDigital HealthHealthtechMedical DevicesAdelaide, AU

Simon Barry(Chief Medical Scientist)inDr Deborah Rathjen(Chief Executive Officer & Managing Director)Professor Shaun McColl(Chief Scientific Officer)

BoardClaudine Bonder(Head, Vascular Biology and Cell Trafficking Laboratory)

Creyoncreyon.comin𝕏

Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides.

AI & Machine LearningBiotechDeep Tech

Matthew Levy(Co-founder)in

Co-investorsLux CapitalDCVC Bio

Creyon Biocreyonbio.comin𝕏

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsBioBritDCVC (Data Collective)DCVC BioAlexandriaCasdin CapitalLux Capital

Curvebeamaicurvebeamai.comin𝕏

CurveBeam AI develops point-of-care cone beam CT imaging systems combined with AI and deep learning tools for orthopedic and bone health applications, including fragility fracture prevention.

AI & Machine LearningHealthtechMedical DevicesHatfield, US

Emyriaemyria.com

Clinical services company collecting patient data and developing novel drug and care models, including MDMA-assisted treatment for PTSD.

Eventsluma.com𝕏

Luma provides a platform for creating event pages, sending invitations, and selling tickets for events.

SaaS

Victor Pontis(Founder)in

Co-investorsAllen Institute for AI (AI2) IncubatorAmplify PartnersBerkley Center for EntrepreneurshipBethnal Green VenturesCedar CapitalEIT Urban Mobility Accelerator+13 more

Humanitixhumanitix.comin

Humanitix operates a non-profit ticketing platform for event hosts and attendees, transforming booking fees into charitable donations for education, healthcare, and social causes worldwide.

ConsumerImpact & Social GoodMarketplacesSaaSSocialPhiladelphia, US

Adam McCurdie(Co-founder)inJoshua Ross(Co-founder)Josh(Co-founder)

Inventiainventia.lifein

Inventia Life Science provides RASTRUM Workflow Paths, tools for generating reproducible 3D cell models for research and drug discovery.

AI & Machine LearningBiotechDeep TechMedical Devices

Co-investorsMain Sequence VenturesVU Venture PartnersBlackbird VenturesSkip Capital

Kantokokantoko.com.auin

Kantoko operates a telehealth platform connecting adults with ADHD specialists for remote diagnosis and treatment planning in Australia.

Digital HealthHealthtechMental HealthAustralia, AU

Co-investorsSide Stage Ventures

LimmaTech Biologicslmtbio.cominFeb 2024acquired by Lilly

LimmaTech develops vaccine technologies and programs designed to combat antimicrobial-resistant pathogens and prevent severe infections.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsAdjuvant CapitalAndera PartnersNovo Holdings

Lumos Diagnosticslumosdiagnostics.comin𝕏

Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Doug Ward(CEO)inPaul Kase(Chief Commercial Officer)in

BoardSam Lanyon(Non-Executive Chair)

Mindsetgetmindset.com𝕏Mar 2023

Mindset is a daily wellness and self-care app featuring audio collections and stories from celebrities and experts.

ConsumerMental HealthWellness & FitnessKing Of Prussia, US

April J Perrymore(Executive Officer, Director, Promoter)Darlene Link(Executive Officer, Director, Promoter)

Co-investorsA.Capital Venturesalphabet angelsTq Ventures LlcUnion Square Ventures (USV)Banana CapitalGold House Ventures+2 more

Mindset Healthmindsethealth.comin𝕏

Mindset Health develops digital health programs using hypnotherapy and mind-body medicine to help patients manage gastrointestinal disorders and improve health outcomes.

Digital HealthHealthtechMedical DevicesMental HealthWellness & FitnessMelbourne, AU

Alex Naoumidis(Co-founder & Co-CEO)inChris Naoumidis(Founder)in

Co-investorsAlberts Impact VenturesFifty YearsKing River CapitalPerennial PartnersY CombinatorAfore Capital+5 more

Onckooncko.comin

Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.

AI & Machine LearningBiotechDeep Tech

Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in

Co-investorsAdverb VenturesIllumina Ventures

Perx Healthperxhealth.comin

Perx develops a digital health platform that uses engagement and behavioral incentive techniques to help older patients, those with chronic conditions, and underserved populations adhere to their treatment plans and manage their health.

Digital HealthHealthtechSaaSAustralia / USA

Hugo Rourke(CEO & Co-founder)inScott(COO & Co-founder)

Co-investorsAirTree VenturesTractor VenturesWildwood Ventures

Plexpcrplexpcr.com

SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers.

BiotechMedical Devices

ProtonIntelprotonintelligence.comin

Proton Intelligence develops CKM™, a continuous monitoring medical device drawing on biosensing and minimally invasive microdevice technology for clinical use.

Deep TechDigital HealthHealthtechMedical Devices

Co-investors15th RockAIN VenturesLongeVC

Proxima Bioproximabio.com.au

Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers.

BiotechHealthtechMedical DevicesMelbourne, AU

Jase(Co-founder)Jon(Co-founder)John McFarland(Executive Officer)Zachary Carpenter(Executive Officer, Director)

BoardJason Pontin(Director)inAlex Gasner(Director)

Co-investorsTin Alley VenturesDCVC (Data Collective)

Psylopsylo.bioMay 2024

Sydney, Nsw

Joshua Ismin(Executive Officer, Director)Samuel Banister(Director)

SpeeDxspeedxpcr.com

SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesSydney, AU

Alison Todd(Co-founder)Elisa Mokany(Co-founder)in

Co-investorsNorthpond Ventures

Stamford Pharmaceuticalsstamfordpharmaceuticals.com

Developing a gene therapy for advanced forms of basal cell carcinoma skin cancer.

Sweetchsweetch.comin𝕏

Sweetch provides AI-driven personalized behavioral interventions that help patients manage chronic conditions through continuous engagement and adaptive recommendations.

AI & Machine LearningDigital HealthHealthtech

Co-investorsEntrée CapitalLionBirdPontifax Venture CapitalTal VenturesOurCrowd

Syndeio Biosciencessyndeio.bioin

Syndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's.

AI & Machine LearningBiotechDigital Health

Co-investorsEvolution VC PartnersCatalio Capital ManagementPalo Santo

Tin Alley Venturestinalleyventures.com

A venture capital firm that invests in the commercialization of research, with a focus on innovations emerging from the University of Melbourne and its affiliated medical research institutions and hospitals in the Melbourne Biomedical Precinct.

BiotechDeep TechImpact & Social GoodMelbourne, AU

Co-investorsAGI HOUSE VENTURESAramco VenturesBTECH CONSORTIUMEJF VenturesLakestarNotion Capital

Verge Genomicsvergegenomics.comin𝕏

Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US

Alice Zhang(Co-founder & CEO)inJason Chen(Cofounder)inEmily Ripka(Head of Product & Engineering)in

Co-investorsAgent CapitalBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture CapitalKarlin Ventures+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CurveBeam AICuttlefishCuttlefish BioRekover TherapeuticsSyndeioXyloYosemite

Exits · 1

1 acquisitions

LimmaTech Biologicsacq. by Lilly

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Tenmile made?
Tenmile has 39 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does Tenmile invest at?
Tenmile invests at the Seed, Series A, Series B, Series C, Growth stages.
What sectors does Tenmile focus on?
Tenmile focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices, Wellness & Fitness.
Who does Tenmile co-invest with?
Tenmile most often shares deals with Booster Innovation Fund, Y Combinator, AirTree Ventures, among 70 tracked co-investors.

Similar investors

Featured in lists